Measurement of Oncostatin M, Leukemia Inhibitory Factor and Interleukin-11 Levels of Patients With Periodontal Disease
Chronic Periodontitis, Generalized, Gingivitis
About this trial
This is an interventional screening trial for Chronic Periodontitis, Generalized focused on measuring Chronic Periodontitis, Gingival Crevicular Fluid, Leukemia Inhibitory Factor, Oncostatin M, Interleukin-11, Periodontal Therapy, Gingivitis
Eligibility Criteria
Inclusion Criteria:
- systemically healthy
- non-smokers
Exclusion Criteria:
- smokers
- pregnancy or lactation
- individuals with any systemic disease
- individuals who have had periodontal treatment in the last six months
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Healthy
Gingivitis
Chronic Periodontitis
included individuals with probing depth (PD) ≤3mm, no sites with attachment loss, and no radiographic evidence of alveolar bone resorption. They exhibited no sign of inflammation (GI=0).
had varying degrees of gingival inflammation (GI≥1), PD≤3mm with no clinical attachment loss or with no alveolar bone destruction.
was defined as those who were with PD ≥ 4mm, clinical attachment loss (CAL) ≥ 2mm, and who had bone loss affecting >30% of the existing teeth on clinical and radiographic examination.